Ipilimumab for Head and Neck Cancer Patients

Condition:   Squamous Cell Carcinoma of the Head and Neck
Intervention:   Drug: Intratumoral Ipilimumab
Sponsors:   Providence Health & Services;   Bristol-Myers Squibb
Not yet recruiting - verified June 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/28RRaQz
via IFTTT